Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 50742-252
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 50742-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Image 02)
This is a report for a combined placebo-controlled trial on Diltiazem Hydrochloride extended-release capsules for angina and hypertension. The report lists the adverse reactions observed in patients who had taken the drug versus a placebo. Adverse reactions such as headaches, dizziness, bradycardia, AV block, edema, and asthenia were reported in varying percentages.*
Image (Image 03)
The text describes capsules of different strengths and sizes, each imprinted with a code on one end and a number indicating its strength on the other end. The capsule with code N365 and 120 strength is white/white and size 2, the one with N366 and 180 strength is light blue/light blue and size 1, the one with N367 and 240 strength is light blue/dark blue and size 0, the one with N368 and 300 strength is dark blue/white and size 00, and the one with N369 and 360 strength is dark blue/dark blue and size 00. The text also indicates that the strength of each capsule is 120 mg.*
Image (Image 04)
120mg-30ct (Image 05)
This is a description of Diltiazem HCI Extended-Release Capsules, USP containing 120 mg of diltiazem hydrochloride. It is a once-a-day drug and comes in a pack of 30 capsules. The package insert contains information about dosage and administration. It is important to keep this and all other drugs out of the reach of children and store it in a tight, light-resistant container with child-resistant closure. The drug should be stored at 25°C (77°F), with allowable excursions to 15°C to 30°C (59°F to 86°F). No excessive humidity should be present. The text also includes prescription details and cautionary information.*
180mg-30ct (Image 06)
Diltiazem HCI is an extended-release drug that comes in 30 capsules per package. Each capsule contains 180 mg Diltiazem hydroct USP. This drug should be kept out of reach of children and stored in light-resistant and child-resistant containers. Recommended storage temperature is 25°C with excursions allowed to 15°C to 30°C. Instructions for dosage and administration can be found in the package insert.*
240mg-30ct (Image 07)
This is a description of a medication called Diltiazem HCI, which comes in extended-release capsules each containing 240 g of the active ingredient. The text provides details on the dosage and administration, storage requirements, and warnings. It also notes that the medication should be kept out of reach of children, dispensed in a child-resistant container, and stored in a dry place at room temperature. If the information on the medication label is unreadable or unclear, it is recommended to seek further guidance from a healthcare provider or pharmacist.*
300mg-30ct (Image 08)
Diltiazem HCI Extended-Release Capsules are available for purchase. Each capsule contains 300mg of Diltiazem hydrochloride. Dosage and Administration information is included in the package insert. It is important to store the drug in a cool, dry place, out of reach of children. The lot number is 00000000 and the expiration date is 00/0000.*
360mg-30ct (Image 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
